Ascentage Pharma Group International - AAPG - Fundamentals

‌
‌

‌

Let's get started...

‌

Breakdown	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	8	6	7	15	12	28	210	222	981	558	568	📊
Revenue Growth (1Y)	--	-17.46%	+7.57%	+113.21%	-14.21%	+124.18%	+651.38%	+5.85%	+341.77%	-43.05%	--	📊
Revenue Growth (5Y)	--	--	--	--	+62.38%	+341.06%	+2980.81%	+1429.55%	+7776.71%	+1901.00%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	+7184.18%	--	📊
Cost of Revenue	0	0	0	2	2	3	22	31	29	132	90	📊
Cost of Revenue Growth (1Y)	--	-100.00%	--	--	-6.20%	+69.28%	+561.00%	+38.84%	-4.77%	+352.91%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+653.26%	--	--	+1357.20%	+1379.40%	+3858.19%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	+50370.71%	--	📊
Gross Profit	7	6	7	12	10	25	188	191	952	427	477	📊
Gross Profit Growth (1Y)	--	-14.56%	+7.57%	+82.42%	-15.57%	+134.47%	+663.62%	+1.99%	+397.05%	-55.15%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	+41.56%	+288.46%	+2657.65%	+1441.77%	+8976.35%	+1636.02%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	+5662.21%	--	📊
Operating Expenses	122	137	331	595	674	894	1,038	1,064	1,321	1,606	1,672	📊
Operating Expenses Growth (1Y)	--	+12.27%	+141.36%	+79.98%	+13.33%	+32.62%	+16.00%	+2.56%	+24.17%	+21.54%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+452.68%	+552.88%	+213.78%	+78.81%	+95.91%	+79.55%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+1216.02%	--	📊
Sell General Administrative	18	13	90	99	64	191	328	376	383	523	556	📊
Research and Development	103	119	250	464	565	766	743	707	947	1,083	1,116	📊
Other Income Expenses	2	5	-9	32	46	-63	-34	-19	-9	0	--	📊
EBITDA	-103	-50	-292	-1,474	-652	-798	-787	-744	-238	-1,095	-1,113	📊
EBITDA Growth (1Y)	--	+51.79%	-486.85%	-405.69%	+55.76%	-22.40%	+1.42%	+5.51%	+68.04%	-360.81%	--	📊
EBITDA Growth (5Y)	--	--	--	--	-533.03%	-1507.05%	-169.95%	+49.56%	+63.57%	-37.17%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	-962.80%	--	📊
Depreciation and Amortization	0	13	18	4	17	17	47	93	93	84	82	📊
Operating Income	-115	-131	-50	-583	-664	-870	-850	-873	-370	-1,179	-1,195	📊
Operating Income Growth (1Y)	--	-14.00%	+61.55%	-1059.68%	-13.95%	-31.01%	+2.30%	-2.69%	+57.63%	-218.92%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-479.24%	-565.68%	-1591.32%	-49.76%	+44.31%	-35.56%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-928.74%	--	📊
Interest Expense	3	58	37	4	6	17	53	96	64	53	26	📊
Pre Tax Income	-108	-120	-347	-1,482	-675	-832	-887	-933	-395	-1,202	-1,224	📊
Tax Provision	0	-2	-2	-2	2	-50	-4	-7	10	7	7	📊
NET INCOME	-108	-119	-345	-1,481	-678	-782	-883	-926	-405	-1,209	-1,231	📊
Net Income Growth (1Y)	--	-9.90%	-191.36%	-328.81%	+54.24%	-15.47%	-12.84%	-4.84%	+56.20%	-198.18%	--	📊
Net Income Growth (5Y)	--	--	--	--	-528.35%	-560.20%	-155.69%	+37.49%	+40.17%	-54.51%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-1021.03%	--	📊
Basic EPS	-8.32	-9.16	-26.68	-112.04	-50.24	-49.12	-53.6	-52.48	-5.36	-13.56	-13.84	📊
Diluted EPS	-8.32	-9.16	-26.68	-112.04	-50.24	-49.12	-53.6	-52.48	-5.36	-13.56	-13.84	📊
Basic Average Shares	13	13	13	13	13	16	16	18	76	89	89	📊
Diluted Average Shares	13	13	13	13	13	16	16	18	76	89	89	📊

Breakdown

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

210

222

981

558

568

📊

Revenue Growth (1Y)

-17.46%

+7.57%

+113.21%

-14.21%

+124.18%

+651.38%

+5.85%

+341.77%

-43.05%

📊

Revenue Growth (5Y)

+62.38%

+341.06%

+2980.81%

+1429.55%

+7776.71%

+1901.00%

📊

Revenue Growth (10Y)

+7184.18%

📊

Cost of Revenue

132

📊

Cost of Revenue Growth (1Y)

-100.00%

-6.20%

+69.28%

+561.00%

+38.84%

-4.77%

+352.91%

📊

Cost of Revenue Growth (5Y)

+653.26%

+1357.20%

+1379.40%

+3858.19%

📊

Cost of Revenue Growth (10Y)

+50370.71%

📊

Gross Profit

188

191

952

427

477

📊

Gross Profit Growth (1Y)

-14.56%

+7.57%

+82.42%

-15.57%

+134.47%

+663.62%

+1.99%

+397.05%

-55.15%

📊

Gross Profit Growth (5Y)

+41.56%

+288.46%

+2657.65%

+1441.77%

+8976.35%

+1636.02%

📊

Gross Profit Growth (10Y)

+5662.21%

📊

Operating Expenses

122

137

331

595

674

894

1,038

1,064

1,321

1,606

1,672

📊

Operating Expenses Growth (1Y)

+12.27%

+141.36%

+79.98%

+13.33%

+32.62%

+16.00%

+2.56%

+24.17%

+21.54%

📊

Operating Expenses Growth (5Y)

+452.68%

+552.88%

+213.78%

+78.81%

+95.91%

+79.55%

📊

Operating Expenses Growth (10Y)

+1216.02%

📊

Sell General Administrative

191

328

376

383

523

556

📊

Research and Development

103

119

250

464

565

766

743

707

947

1,083

1,116

📊

Other Income Expenses

-9

-63

-34

-19

-9

📊

EBITDA

-103

-50

-292

-1,474

-652

-798

-787

-744

-238

-1,095

-1,113

📊

EBITDA Growth (1Y)

+51.79%

-486.85%

-405.69%

+55.76%

-22.40%

+1.42%

+5.51%

+68.04%

-360.81%

📊

EBITDA Growth (5Y)

-533.03%

-1507.05%

-169.95%

+49.56%

+63.57%

-37.17%

📊

EBITDA Growth (10Y)

-962.80%

📊

Depreciation and Amortization

📊

Operating Income

-115

-131

-50

-583

-664

-870

-850

-873

-370

-1,179

-1,195

📊

Operating Income Growth (1Y)

-14.00%

+61.55%

-1059.68%

-13.95%

-31.01%

+2.30%

-2.69%

+57.63%

-218.92%

📊

Operating Income Growth (5Y)

-479.24%

-565.68%

-1591.32%

-49.76%

+44.31%

-35.56%

📊

Operating Income Growth (10Y)

-928.74%

📊

Interest Expense

📊

Pre Tax Income

-108

-120

-347

-1,482

-675

-832

-887

-933

-395

-1,202

-1,224

📊

Tax Provision

-2

-50

-4

-7

📊

NET INCOME

-108

-119

-345

-1,481

-678

-782

-883

-926

-405

-1,209

-1,231

📊

Net Income Growth (1Y)

-9.90%

-191.36%

-328.81%

+54.24%

-15.47%

-12.84%

-4.84%

+56.20%

-198.18%

📊

Net Income Growth (5Y)

-528.35%

-560.20%

-155.69%

+37.49%

+40.17%

-54.51%

📊

Net Income Growth (10Y)

-1021.03%

📊

Basic EPS

-8.32

-9.16

-26.68

-112.04

-50.24

-49.12

-53.6

-52.48

-5.36

-13.56

-13.84

📊

Diluted EPS

-8.32

-9.16

-26.68

-112.04

-50.24

-49.12

-53.6

-52.48

-5.36

-13.56

-13.84

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	8	6	7	15	12	28	210	222	981	558	568	📊
Revenue Growth (1Y)	--	-17.46%	+7.57%	+113.21%	-14.21%	+124.18%	+651.38%	+5.85%	+341.77%	-43.05%	--	📊
Revenue Growth (5Y)	--	--	--	--	+62.38%	+341.06%	+2980.81%	+1429.55%	+7776.71%	+1901.00%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	+7184.18%	--	📊
Cost of Revenue	0	0	0	2	2	3	22	31	29	132	90	📊
Cost of Revenue Growth (1Y)	--	-100.00%	--	--	-6.20%	+69.28%	+561.00%	+38.84%	-4.77%	+352.91%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+653.26%	--	--	+1357.20%	+1379.40%	+3858.19%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	+50370.71%	--	📊
Gross Profit	7	6	7	12	10	25	188	191	952	427	477	📊
Gross Profit Growth (1Y)	--	-14.56%	+7.57%	+82.42%	-15.57%	+134.47%	+663.62%	+1.99%	+397.05%	-55.15%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	+41.56%	+288.46%	+2657.65%	+1441.77%	+8976.35%	+1636.02%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	+5662.21%	--	📊
Operating Expenses	122	137	331	595	674	894	1,038	1,064	1,321	1,606	1,672	📊
Operating Expenses Growth (1Y)	--	+12.27%	+141.36%	+79.98%	+13.33%	+32.62%	+16.00%	+2.56%	+24.17%	+21.54%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+452.68%	+552.88%	+213.78%	+78.81%	+95.91%	+79.55%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+1216.02%	--	📊
Sell General Administrative	18	13	90	99	64	191	328	376	383	523	556	📊
Research and Development	103	119	250	464	565	766	743	707	947	1,083	1,116	📊
Other Income Expenses	2	5	-9	32	46	-63	-34	-19	-9	0	--	📊
EBITDA	-103	-50	-292	-1,474	-652	-798	-787	-744	-238	-1,095	-1,113	📊
EBITDA Growth (1Y)	--	+51.79%	-486.85%	-405.69%	+55.76%	-22.40%	+1.42%	+5.51%	+68.04%	-360.81%	--	📊
EBITDA Growth (5Y)	--	--	--	--	-533.03%	-1507.05%	-169.95%	+49.56%	+63.57%	-37.17%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	-962.80%	--	📊
Depreciation and Amortization	0	13	18	4	17	17	47	93	93	84	82	📊
Operating Income	-115	-131	-50	-583	-664	-870	-850	-873	-370	-1,179	-1,195	📊
Operating Income Growth (1Y)	--	-14.00%	+61.55%	-1059.68%	-13.95%	-31.01%	+2.30%	-2.69%	+57.63%	-218.92%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-479.24%	-565.68%	-1591.32%	-49.76%	+44.31%	-35.56%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-928.74%	--	📊
Interest Expense	3	58	37	4	6	17	53	96	64	53	26	📊
Pre Tax Income	-108	-120	-347	-1,482	-675	-832	-887	-933	-395	-1,202	-1,224	📊
Tax Provision	0	-2	-2	-2	2	-50	-4	-7	10	7	7	📊
NET INCOME	-108	-119	-345	-1,481	-678	-782	-883	-926	-405	-1,209	-1,231	📊
Net Income Growth (1Y)	--	-9.90%	-191.36%	-328.81%	+54.24%	-15.47%	-12.84%	-4.84%	+56.20%	-198.18%	--	📊
Net Income Growth (5Y)	--	--	--	--	-528.35%	-560.20%	-155.69%	+37.49%	+40.17%	-54.51%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-1021.03%	--	📊
Basic EPS	-8.32	-9.16	-26.68	-112.04	-50.24	-49.12	-53.6	-52.48	-5.36	-13.56	-13.84	📊
Diluted EPS	-8.32	-9.16	-26.68	-112.04	-50.24	-49.12	-53.6	-52.48	-5.36	-13.56	-13.84	📊
Basic Average Shares	13	13	13	13	13	16	16	18	76	89	89	📊
Diluted Average Shares	13	13	13	13	13	16	16	18	76	89	89	📊

Breakdown

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

210

222

981

558

568

📊

Revenue Growth (1Y)

-17.46%

+7.57%

+113.21%

-14.21%

+124.18%

+651.38%

+5.85%

+341.77%

-43.05%

📊

Revenue Growth (5Y)

+62.38%

+341.06%

+2980.81%

+1429.55%

+7776.71%

+1901.00%

📊

Revenue Growth (10Y)

+7184.18%

📊

Cost of Revenue

132

📊

Cost of Revenue Growth (1Y)

-100.00%

-6.20%

+69.28%

+561.00%

+38.84%

-4.77%

+352.91%

📊

Cost of Revenue Growth (5Y)

+653.26%

+1357.20%

+1379.40%

+3858.19%

📊

Cost of Revenue Growth (10Y)

+50370.71%

📊

Gross Profit

188

191

952

427

477

📊

Gross Profit Growth (1Y)

-14.56%

+7.57%

+82.42%

-15.57%

+134.47%

+663.62%

+1.99%

+397.05%

-55.15%

📊

Gross Profit Growth (5Y)

+41.56%

+288.46%

+2657.65%

+1441.77%

+8976.35%

+1636.02%

📊

Gross Profit Growth (10Y)

+5662.21%

📊

Operating Expenses

122

137

331

595

674

894

1,038

1,064

1,321

1,606

1,672

📊

Operating Expenses Growth (1Y)

+12.27%

+141.36%

+79.98%

+13.33%

+32.62%

+16.00%

+2.56%

+24.17%

+21.54%

📊

Operating Expenses Growth (5Y)

+452.68%

+552.88%

+213.78%

+78.81%

+95.91%

+79.55%

📊

Operating Expenses Growth (10Y)

+1216.02%

📊

Sell General Administrative

191

328

376

383

523

556

📊

Research and Development

103

119

250

464

565

766

743

707

947

1,083

1,116

📊

Other Income Expenses

-9

-63

-34

-19

-9

📊

EBITDA

-103

-50

-292

-1,474

-652

-798

-787

-744

-238

-1,095

-1,113

📊

EBITDA Growth (1Y)

+51.79%

-486.85%

-405.69%

+55.76%

-22.40%

+1.42%

+5.51%

+68.04%

-360.81%

📊

EBITDA Growth (5Y)

-533.03%

-1507.05%

-169.95%

+49.56%

+63.57%

-37.17%

📊

EBITDA Growth (10Y)

-962.80%

📊

Depreciation and Amortization

📊

Operating Income

-115

-131

-50

-583

-664

-870

-850

-873

-370

-1,179

-1,195

📊

Operating Income Growth (1Y)

-14.00%

+61.55%

-1059.68%

-13.95%

-31.01%

+2.30%

-2.69%

+57.63%

-218.92%

📊

Operating Income Growth (5Y)

-479.24%

-565.68%

-1591.32%

-49.76%

+44.31%

-35.56%

📊

Operating Income Growth (10Y)

-928.74%

📊

Interest Expense

📊

Pre Tax Income

-108

-120

-347

-1,482

-675

-832

-887

-933

-395

-1,202

-1,224

📊

Tax Provision

-2

-50

-4

-7

📊

NET INCOME

-108

-119

-345

-1,481

-678

-782

-883

-926

-405

-1,209

-1,231

📊

Net Income Growth (1Y)

-9.90%

-191.36%

-328.81%

+54.24%

-15.47%

-12.84%

-4.84%

+56.20%

-198.18%

📊

Net Income Growth (5Y)

-528.35%

-560.20%

-155.69%

+37.49%

+40.17%

-54.51%

📊

Net Income Growth (10Y)

-1021.03%

📊

Basic EPS

-8.32

-9.16

-26.68

-112.04

-50.24

-49.12

-53.6

-52.48

-5.36

-13.56

-13.84

📊

Diluted EPS

-8.32

-9.16

-26.68

-112.04

-50.24

-49.12

-53.6

-52.48

-5.36

-13.56

-13.84

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-12.99%
Next Earnings
Market cap	398.19M (USD)
EPS (TTM)	-13.84 ($)
P/E (TTM)	-1.24 ($)
Last Close	17.20

Next Earnings
Market cap	398.19M (USD)
EPS (TTM)	-13.84 ($)
P/E (TTM)	-1.24 ($)
Last Close	17.20 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-12.99%
Next Earnings
Market cap	398.19M (USD)
EPS (TTM)	-13.84 ($)
P/E (TTM)	-1.24 ($)
Last Close	17.20

Next Earnings
Market cap	398.19M (USD)
EPS (TTM)	-13.84 ($)
P/E (TTM)	-1.24 ($)
Last Close	17.20 ($)